Volume : X, Issue : V, May - 2020

Magnitude of Hydroxychloroquine: a mini Review

Vyshnavi V Rao, Shamsiya Rizwana

Abstract :

Hydroxychloroquine is a well–established orally administered antimalarial approved in 1950’s. Sold under the and name Plaquenil, it is used as a treatment to wide spectrum of diseases like rheumatoid arthritis, cancer, viral diseases and is associated with the prevention of treatment–induced manifestations like diabetes mellitus and thrombosis. It has shown promising In–Vitro results against the 2004 SARS [Severe Acute Respiratory Syndrome] Coronavirus1. Late 2019 and early 2020 has seen a rapid spread of the novel SARS–CoV–2 that caused COVID 19 pandemic. The US–Food and Drug Administration has approved Hydroxychloroquine as potential treatment to COVID 19 coronavirus. This review, discusses current literature on applications, immunomodulatory mechanism, potential side effects, structural characteristics and pharmacokinetics associated with Hydroxychloroquine

Keywords :

Article: Download PDF    DOI : 10.36106/ijar  

Cite This Article:

MAGNITUDE OF HYDROXYCHLOROQUINE: A MINI REVIEW, Vyshnavi V Rao, Shamsiya Rizwana INDIAN JOURNAL OF APPLIED RESEARCH : Volume-10 | Issue-5 | May-2020

Number of Downloads : 157

References :